You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cutaneous T-Cell Lymphoma (CTLC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Cutaneous T-cell Lymphoma Retreated With Brentuximab Vedotin

Not yet recruiting
  • T-Cell Lymphoma
  • No intervention
  • Bordeaux, France
  • +10 more
May 24, 2023

Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,

Not yet recruiting
  • Mycosis Fungoides of Skin (Diagnosis)
  • +5 more
  • Med-Jet Injector
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023

Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

Recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Durvalumab
  • +2 more
  • Duarte, California
  • +3 more
Jan 12, 2023

Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • Fungoides Mycosis Sezary Syndrome
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Jul 13, 2023

Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

Recruiting
  • Cutaneous T Cell Lymphoma
  • Peripheral T Cell Lymphoma
  • Microdevices
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 16, 2022

Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma

Recruiting
  • Lymphoma, T-cell, Peripheral
  • Lymphoma, T-cell, Cutaneous
  • Nagoya, Japan
  • +2 more
Nov 24, 2022

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

Not yet recruiting
  • T-cell Lymphoma
  • +10 more
  • Chicago, Illinois
    Rush University Medical Center
Oct 24, 2022

Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • +2 more
    • Ancona, Italy
    • +19 more
    Nov 2, 2023

    Cutaneous T Cell Lymphoma Trial in Chicago (APR-TD011 (RLF-TD011))

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • APR-TD011 (RLF-TD011)
    • Chicago, Illinois
      Dermatology CTU
    Feb 6, 2023

    Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

    Recruiting
    • Recurrent Adult T-Cell Leukemia/Lymphoma
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 18, 2022

    Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) Trial in United States (SIM1811-03)

    Recruiting
    • Advanced Solid Tumor
    • Cutaneous T-cell Lymphoma (CTCL)
    • Detroit, Michigan
    • +5 more
    Oct 6, 2022

    Recurrent Anaplastic Large Cell Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Mature T- and NK-Cell

    Active, not recruiting
    • Recurrent Anaplastic Large Cell Lymphoma
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 30, 2023

    T-Cell Lymphoma Trial (Brentuximab vedotin)

    Not yet recruiting
    • T-Cell Lymphoma
    • Brentuximab vedotin
    • (no location specified)
    Jun 30, 2022

    Mycosis Fungoides Trial in Edmonton (Cemiplimab)

    Not yet recruiting
    • Mycosis Fungoides
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Sep 12, 2022

    Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin)

    Completed
    • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
    • Fairport, New York
      Rochester Skin Lymphoma Medical Group
    Aug 24, 2022

    Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in New York (UVADEX® (methoxsalen) Sterile Solution in conjunction with the

    Recruiting
    • Cutaneous T Cell Lymphoma
    • Mycosis Fungoides
    • UVADEX® (methoxsalen) Sterile Solution in conjunction with the UVAR® THERAKOS® CELLEX Photopheresis
    • THERAKOS® CELLEX photopheresis system
    • New York, New York
      Herbert Irving Pavilion
    Dec 23, 2022

    Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Grade 1

    Active, not recruiting
    • Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
    • +18 more
    • Anti-ICOS Monoclonal Antibody MEDI-570
    • +2 more
    • Duarte, California
    • +22 more
    Jan 18, 2023

    Tissue Repository: CTCL Collection Protocol

    Recruiting
    • Lymphoma, T-Cell, Cutaneous
    • +2 more
      • New York, New York
        Columbia University Medical Center
      May 2, 2022

      Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

      Active, not recruiting
      • Folliculotropic Mycosis Fungoides
      • +7 more
      • Extracorporeal Photopheresis
      • +3 more
      • Duarte, California
        City of Hope Medical Center
      Dec 8, 2022

      Cutaneous T Cell Lymphoma Trial in Pittsburgh (Micro needle array-Doxorubicin (MNA-D))

      Recruiting
      • Cutaneous T Cell Lymphoma
      • Micro needle array-Doxorubicin (MNA-D)
      • Pittsburgh, Pennsylvania
        University Of Pittsburgh Medical Center
      Jun 2, 2022

      Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid

      Active, not recruiting
      • Mycoses
      • +5 more
      • anti-thymocyte globulin
      • +2 more
      • Stanford, California
        Stanford University School of Medicine
      Jun 16, 2022

      Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL) Trial in United States (KT-333)

      Recruiting
      • Non Hodgkin Lymphoma (NHL)
      • +4 more
      • Orange, California
      • +8 more
      Nov 29, 2022